IN Brief:
- Celleste Bio has unveiled milk chocolate bars made with cell-cultured cocoa butter supplied to Mondelēz.
- The work is positioned as a step from technical proof toward commercial-scale cocoa ingredient supply.
- The story lands as cocoa sourcing remains exposed to climate, traceability, and supply volatility.
Celleste Bio has moved its cell-cultured cocoa programme into a more commercially credible phase after milk chocolate bars were produced using the company’s cocoa butter in collaboration with Mondelēz International. The bars are being presented as a technical milestone for an alternative cocoa ingredient platform that is trying to address one of confectionery’s most exposed supply risks.
The key point is not simply that a novel ingredient exists. Cocoa alternatives have appeared in different forms before, from reformulation systems to fermentation-based approaches and ingredient extenders. What gives this development more weight is that the butter was used in finished milk chocolate bars produced with a major manufacturer, rather than being left at bench-scale demonstration or ingredient-only disclosure. Celleste says the work shows its cocoa butter can function as a drop-in ingredient while maintaining the melt, texture, and sensory behaviour expected in conventional chocolate.
The company, which has been developing cocoa ingredients through cell suspension culture, is positioning the ingredient as bio-identical cocoa butter produced in controlled bioreactors rather than through traditional cultivation. It has also tied the latest milestone to a broader scale-up strategy, saying the bars clear the way for market-ready quantities over the next two years. That remains an ambitious manufacturing challenge, but it shifts the conversation from novelty to process economics, specification control, and industrial repeatability.
For confectionery manufacturers, cocoa butter is one of the least forgiving ingredients to tinker with. Function matters as much as flavour. Tempering behaviour, snap, viscosity, gloss, and melt profile all depend on a narrow technical window. Any alternative positioned for mainstream chocolate production has to prove far more than headline sustainability credentials. It has to work in an existing factory environment, across real formulations, with acceptable cost and consistency. That is why finished bars, even at this early stage, matter more than abstract claims about future disruption.
The commercial backdrop is doing part of the work for Celleste. Cocoa has become one of the food industry’s clearest examples of climate-linked supply fragility, with disease pressure, weather volatility, and broader sourcing instability all feeding through into availability and cost. That does not mean conventional cocoa is about to be displaced. It does mean larger manufacturers are more willing to examine technologies that can supplement supply, stabilise product development, and reduce exposure to agricultural shocks in specific categories or formats.
There is also a formulation opportunity buried inside the supply story. Celleste is not only talking about replacement. It is also talking about tailoring cocoa butter properties through computational modelling and controlled production. If that becomes technically and economically viable, the platform could offer confectionery R&D teams something more valuable than a simple substitute: an ingredient that can be designed around process conditions, finished-product targets, or warm-climate stability. That possibility is still early, but it explains why strategic partners are paying attention.
The hard part now begins. Scale-up in food biotechnology is where many promising ingredient stories become slower, costlier, and more operationally complex than early coverage suggests. Chocolate makers will want to know what a commercial specification looks like, how quickly supply can be ramped, how the ingredient will be regulated across markets, and where price will land against conventional cocoa butter in an already pressured market. None of those questions are resolved by a dozen bars.
Still, the milestone is significant. It brings cultured cocoa butter out of the lab-and-slide-deck phase and into product validation with a manufacturer that understands the industrial demands of chocolate. In a category wrestling with raw-material instability, that alone makes it worth serious attention.
